Physician profile
Jenny Thomas
NPI 1558628172
$1,161.65
in general payments reported to CMS, 2019-2025
17 companies · $127 in 2025
The $127 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $195 · 2020: $112 · 2021: $89.53 · 2022: $184 · 2023: $254 · 2024: $200 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $581.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $580.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $356.37 | 2020-2024 | Jornay Pm |
| Corium, LLC | $269.97 | 2021-2025 | Azstarys |
| Pfizer INC. | $87.31 | 2019-2025 | |
| Tris Pharma INC | $79.52 | 2019-2022 | |
| Genentech USA, INC. | $74.76 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $57.54 | 2025 | Jornay Pm |
| Takeda Pharmaceuticals U.S.A., INC. | $36.86 | 2019-2021 | |
| Neos Therapeutics, LP | $36.14 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $35.30 | 2023-2024 | Flumist Quadrivalent |
| Alk-Abello, INC | $24.70 | 2025 | Neffy, Grastek, Odactra |
| Merck Sharp & Dohme LLC | $17.20 | 2023 | Gardasil 9, M-M-R II, Rotateq |
| Adlon Therapeutics L.P. | $16.25 | 2019 | |
| Adaptive Biotechnologies Corporation | $15.49 | 2024 | Clonoseq |
| Cranial Technologies, INC | $15.09 | 2020 | |
| Puma Biotechnology, INC. | $13.32 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $13.08 | 2025 | |
| Supernus Pharmaceuticals, INC. | $12.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenny Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.